Shopping Cart


Your shopping bag is empty

Go to the shop

Vitamin K2, 100mcg 90 Veg Caps

This product is restricted to professional customers only.
Please Log in to purchase this product.

Add to Wishlist

Vitamin K2 in an easy-to-use vegetarian capsule. Provides 100 mcg per serving of vitamin K2 as menaquinone-7 (MK-7). Vegetarian and Vegan Friendly.


      • Cardiovascular Health - myocardial infarction, stroke, plaque instability, vascular calcification, coronary heart disease, aortic calcification
      • Bones  -
      • Health - cancer, diabetes, immune function

            Feature Ingredients

            • MK-7 has the greatest half-life of all forms of vitamin K, as well as the best extra-hepatic distribution
            • Vitamin K2, particularly MK-7, allows for much lower dosing with significant clinical benefit
            • Extracted from natto beans, the food-based highest naturally occurring MK-7

                              • Discovery of vitamin K-dependent (VKD) post-translational modification of proteins involved not only in coagulation, but also in bone metabolism, vascular calcification, cell growth regulation, and even ATP production has dramatically shifted both the physiological and clinical importance of this enzymatic cofactor.1,2,3
                              • VKD proteins have a nearly ubiquitous presence in diverse cell types, and modification by γ-carboxylation is necessary for biological activity. Dietary intake of vitamin K is often insufficient, and vitamin K is diverted to those enzymes critical to short term survival (e.g. coagulation), leading to suboptimal carboxylation of VKD proteins associated with aging and chronic disease, such as matrix Gla protein, osteocalcin and Gas6.4
                              • Clinically, a lower intake of vitamin K has translated into a greater risk for myocardial infarction and stroke, plaque instability, and most recently, diabetes.5,6 A greater intake of vitamin K, particularly K2, has been associated with lower all-cause mortality, coronary heart disease, aortic calcification, as well as cancer incidence and fatality.7,8 Higher intake of MK-7, which has the longest half-life and the most extra-hepatic distribution, has been associated with lower risk of fracture and greater BMD.9-13

                                      Service Size: 1 Vegetarian Cap

                                      Servings per Container: 90

                                      Medicinal Ingredients

                                      Each Vegetarian Capsule Contains:

                                      Vitamin K2 (Menaquinone) (MK-7) (Natto Bean)             100 mcg

                                      Non-Medicinal Ingredients

                                      Microcrystalline cellulose, vegetarian capsule (carbohydrate gum [cellulose], purified water), vegetable grade magnesium stearate (lubricant).  


                                      Contains No Added: artificial colours, preservatives, or sweeteners; dairy, sugar,  wheat, gluten, yeast, corn, egg, fish, shellfish, animal products,  salt, tree nuts, or GMOs. Suitable for Vegetarians/Vegans.

                                      Recommended Use

                                      Adults 19+: 1 capsule per day or as directed by a health care practitioner. 

                                      Bioclinic Naturals Advantage

                                      Highly bioavailable ingredients for optimal absorption.


                                      Do not use if you are hypersensitive or allergic to any of the ingredients.


                                      Consult a health care practitioner prior to use if you are taking any medications (especially blood thinners) or if you have any pre-existing condition. Discontinue this product 2 weeks prior to surgery.

                                      Vitamin K may antagonize the effect of some anticoagulant medications, particularly warfarin, and should be taken together only with medical supervision. Recent data suggests vitamin K supplementation may stabilize INR’s and reduce adverse effects among those on vitamin K antagonists, but combined use should be carefully monitored.14,15

                                      Side Effect Risks

                                      Discontinue use and consult a healthcare practitioner if symptoms persist, worsen or you develop any reactions which may include: allergy or intolerance.  Keep out of reach of children. Sealed for your protection. Do not use if seal is broken. For freshness, store in a cool, dry place.


                                      The information and product descriptions that appear on this website are for information and educational purposes only and are not intended to provide or replace medical advice to individuals from qualified health care professionals. Consult your physician if you have any health concerns, and before initiating any new dietary, exercise, supplements or other lifestyle changes.


                                      1. Vos M, et al. Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency. Science. 2012 Jun 8;336(6086):1306-10.
                                      2. Vermeer C. Vitamin K: the effect on health beyond coagulation - an overview. Food Nutr Res. 2012;56. doi: 10.3402/fnr.v56i0.5329.
                                      3. Chatrou ML, et al. Role of vitamin K-dependent proteins in the arterial vessel wall. Hamostaseologie. 2011 Nov;31(4):251-7.
                                      4. McCann JC, et al. Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging? Am J Clin Nutr. 2009 Oct;90(4):889-907.
                                      5. Ibarrola-Jurado N, et al. Dietary phylloquinone intake and risk of type 2 diabetes in elderly subjects at high risk of cardiovascular disease. Am J Clin Nutr. 2012 Oct 3. [Epub ahead of print].
                                      6. Schurgers LJ, et al. Vitamin k-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype. PLoS One. 2012;7(8):e43229.
                                      7. Geleijnse JM, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J. Nutr. 2004. 134:3100–5.
                                      8. Nimptsch K, et al. Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Am J Clin Nutr. 2010 May;91(5):1348-58.
                                      9. Schurgers LJ, et al. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood. 2007 Apr 15;109(8):3279-83.
                                      10. Katsuyama H, et al. Usual dietary intake of fermented soybeans (natto) is associated with bone mineral density in premenopausal women. J. Nutr. Sci. Vitaminol. (Tokyo) 2002. 48:207–15.
                                      11. Ikeda Y, et al. Intake of fermented soybeans, natto, is associated with reduced bone loss in postmenopausal women: Japanese Population-Based Osteoporosis Study (JPOS). J. Nutr. 2006. 136:1323–28.
                                      12. Fujita Y, et al. Association between vitamin K intake from fermented soybeans, natto, and bone mineral density in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) study. Osteoporos Int. 2011 Mar 11. [Epub ahead of print].
                                      13. Cockayne S, et al. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2006 Jun 26;166(12):1256-61.
                                      14. Ford SK, et al. Vitamin K supplementation to decrease variability of International Normalized Ratio in patients on vitamin K antagonists: a literature review. Curr Opin Hematol. 2008 Sep;15(5):504-8.
                                      15. Weijs B, et al. Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. Eur Heart J. 2011 Oct;32(20):2555-62.